Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Zillion Pharmachem Ltd (ZILONPHARM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524476 NSE: ZILONPHARM Pharmaceuticals & Drugs | | Zillion Pharmachem Share Price
BSE Share Price
Not Listed
Not Listed
Zillion Pharmachem Ltd (ZILONPHARM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524476 NSE: ZILONPHARM Pharmaceuticals & Drugs | | Zillion Pharmachem Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
-
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
-
Equity
-
Face Value
-
All Time Low / High
₹0.50 / 140.00
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Information and data for this Company is currently unavailable.
We assure our users that information and data for the company will be available soon.
We assure our users that information and data for the company will be available soon.
Valuation of Zillion Pharmachem - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
No Data To Display
Promoter's Holding & Share Pledging
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Zillion Pharmachem Ltd FAQs
The current trading price of Zillion Pharmachem on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zillion Pharmachem stood at ₹0.00 Cr
The latest P/E ratio of Zillion Pharmachem as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Zillion Pharmachem as of 31-Dec-1969 is 0.00.
The 52-week high of Zillion Pharmachem is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zillion Pharmachem is ₹0.00 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Zillion Pharmachem Ltd
Zillion Pharmachem was incorporated on Aprril 24, 1992. It was promoted by Amit Shah, Bina Shah and Prafulchandra Barot. ZPL manufactures bulk drugs such as antendol, nifedipine, chloro pheniramine, trimethoprim, propanolol HCl and formulations such as ointments, injectables, syrups, capsules, tablets. It markets products under the brand names Zillion and Zee.
It entered into collaboration with Cuba Pharma Havana, Cuba, for products like Hepatitis B Surface Antigen vaccine, Streptokines, Facdermin cream, Meningocolol vaccine B & C, AIDS testing kits, and monoclonal antibiotics. ZPL has export orders worth Rs. 8.5 cr on hand. Export orders amounting to full capacity utilisation have been received from Dubai, Saudi Arabia, Indonesia, Singapore, Thailand, etc
The scrip of the company is suspended for trading since November 30, 2007.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
